Fast clinical response with topical ruxolitinib in the management of non-segmental vitiligo detected by VISIA<sup>®</sup> analysis system
Dear Editor, Vitiligo is an acquired, chronic depigmenting disorder characterized by the progressive loss of epidermal melanocytes. Leukotrichia, present in approximately 10% to 60% of cases, results from the loss of melanocytes within the hair follicles. Clinically, it manifests as well-demarcated, nonscaling depigmented macules that may coalesce and expand over time. [...].
Institutions
- Ospedale Santa Maria Goretti (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Dermatology Reports
- Published
- 2025-12-19
- DOI
- https://doi.org/10.4081/dr.2025.10527
- Primary Topic
- melanin and skin pigmentation
- Type
- article
- Field-Weighted Citation Impact
- 0.00